High serum YKL-40 level is associated with poor prognosis in patients with lung cancer.

Journal: Tuberkuloz ve toraks
PMID: 30683021

Abstract

INTRODUCTION: YKL-40 is a glycoprotein that plays role in inflammation and malignant processes. High serum YKL-40 levels are associated with short survive in cancer and chronic obstructive pulmonary disease (COPD) is another reason to increase its' level. However, limited knowledges are known in YKL-40 along with lung cancer and COPD.

Authors

  • Aydın Çiledağ
    Department of Chest Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Pınar Akın Kabalak
    Clinic of Chest Diseases, Ankara Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara, Turkey.
  • Gökhan Çelik
    Department of Chest Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Nalan Demir
    Department of Chest Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Cabir Yüksel
    Department of Chest Surgery, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Gözde Köycü
    Department of Chest Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Derya Gökmen Öztuna
    Department of Biostatistics, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Abbas Yousefi Rad
    Clinical Laboratory, TOBB Economics and Technology University, Ankara, Turkey.
  • Akın Kaya
    Department of Chest Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Hakan Kutlay
    Department of Chest Surgery, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • İsmail Savaş
    Department of Chest Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Numan Numanoğlu
    Department of Chest Diseases, TOBB Economics and Technology University, Faculty of Medicine, Ankara, Turkey.

Keywords

External Resources

Popular Topics
Recent Journals